Search Results 441-450 of 11930 for Ibrance
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
This randomized, active controlled, multicenter Phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with ...
The use of this lotion is considered investigational since it hasn't been studied in lymphoma cancer patients with low magnesium levels before; however, the FDA ...
The purpose of this study is to evaluate response, survival, safety, and tolerability of treatment with lenvatinib for patients who have anaplastic thyroid ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
The collected tissue specimens will be used to develop preclinical models; i.e., cell lines, patient derived micro-cancer models as well as patient-derived ...
About this study. This phase II trial studies the side effects and how well ibrutinib works in treating patients with chronic lymphocytic leukemia who ...
The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.